APA

Jovčevska I., Zupanec N., Urlep Ž., Vranič A., Matos B., Stokin C. L., Muyldermans S., Myers M. P., Buzdin A. A., Petrov I. & Komel R. (20180406). Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates. : Oncotarget.

Chicago

Jovčevska Ivana, Zupanec Neja, Urlep Žiga, Vranič Andrej, Matos Boštjan, Stokin Clara Limbaeck, Muyldermans Serge, Myers Michael P, Buzdin Anton A, Petrov Ivan and Komel Radovan. 20180406. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates. : Oncotarget.

Harvard

Jovčevska I., Zupanec N., Urlep Ž., Vranič A., Matos B., Stokin C. L., Muyldermans S., Myers M. P., Buzdin A. A., Petrov I. and Komel R. (20180406). Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates. : Oncotarget.

MLA

Jovčevska Ivana, Zupanec Neja, Urlep Žiga, Vranič Andrej, Matos Boštjan, Stokin Clara Limbaeck, Muyldermans Serge, Myers Michael P, Buzdin Anton A, Petrov Ivan and Komel Radovan. Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates. : Oncotarget. 20180406.